HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lorin K Johnson Selected Research

balsalazide (Colazal)

11/2009Chemoprevention of colonic polyps with balsalazide: an exploratory, double-blind, placebo-controlled study.
1/2003Treatment of ulcerative colitis with balsalazide: response to editorial by Drs. Farrell and Peppercorn and letter to the editor by Dr. Hanauer.
12/2002Balsalazide is superior to mesalamine in the time to improvement of signs and symptoms of acute mild-to-moderate ulcerative colitis.
6/2002A randomized, double blind, dose-response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate ulcerative colitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lorin K Johnson Research Topics

Disease

3Ulcerative Colitis
01/2003 - 06/2002
2Hemorrhage
12/2002 - 06/2002
1Colonic Polyps
11/2009
1Adenoma (Adenomas)
11/2009
1Neoplasms (Cancer)
11/2009
1Polyps
11/2009
1Crohn Disease (Crohn's Disease)
08/2005

Drug/Important Bio-Agent (IBA)

4balsalazide (Colazal)FDA LinkGeneric
11/2009 - 06/2002
3Mesalamine (Mesalazine)FDA LinkGeneric
11/2009 - 06/2002
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
11/2009
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
11/2009
1VitaminsIBA
11/2009
1CalciumIBA
11/2009
1Folic Acid (Vitamin M)FDA LinkGeneric
11/2009
1ProdrugsIBA
11/2009
1Rifaximin (L 105)FDA Link
08/2005
1TabletsIBA
06/2002

Therapy/Procedure

1Chemoprevention
11/2009